Scheduled for June 23 rd the CD19 Vaccine for cancer.A small company located in Texas will release it’s findings and results
from 110 clinical trials on a treatment centered on a patients immune
system where the T cell will recognize and phagotize the cancer cell.
The release of their findings should lead to licensing fees that should
cause the price of the stock to explode.
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
just read a ton of articles on the methodology and techniques of CD-19. Tes Bellicum seems to be the company and there are at least 8 research oriented companies investigating the T cell killing effects on many cancers once the T cells can identify a cancer cell. Protein antigen (outside) and inside as well as genetic modification of the T cells allows recognition and attack .There’s not much word on cancers other than blood types, but this concept should be able to adapt to most.
Bellicum Pharmaceutical from Houston TX is the co. Most of these CD19 T cell drugs/ vaccines only work on blood deseases. They have 1 clinical trial going but not on CD19. The skinny is that they found a way to work solid tumor s
BLCM—65.6% owned by institutions—12.57% short float–Bellicum Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers, solid tumors, and orphan inherited blood disorders in the United States and internationally. Its clinical product candidate is BPX-501, an adjunct T-cell therapy in multiple Phase I/II clinical trials, administered after allogeneic hematopoietic stem cell transplantation. The company’s preclinical product candidates include BPX-601, a GoCAR-T product candidate for treating solid tumors expressing the prostate stem cell antigen; and BPX-701, a T cell receptors (TCR) product candidate for the treatment of solid tumors expressing the preferentially-expressed antigen in melanoma. It has a collaboration agreement with Adaptimmune Therapeutics plc to evaluate, develop, and commercialize T-cell therapies; Ospedale Pediatrico Bambino Gesu for the design and development of various T cell immunotherapies; and Academisch Ziekenhuis Leiden for research to discover and validate high-affinity TCR product candidates targeting various cancer-associated antigens. Bellicum Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Houston, Texas.
I recently heard that senator John McCain was diagnosed with a brain tumor. Would He be a likely candidate for the CD19 vaccine?
I SUBSCRIBE TO A FINANCIAL NEWS LETTER THAT TURNED ME ON TO THE TINY LITTLE TEXAS BIOTECH AND THEY CHUMMED THE WATER WITH HUGE RETURNS BUT NEVER EVER GAVE ME TICKER SYMBOL FOR THE STOCK. JUST PUSH TO SELL ME A $2000 INFORMATION PACKET. WHY AM I PAYING THE MONEY IF THEY WILL NOT GIVE ME THE TICKER SYMBOL. I ABSOLUTELY HATE TO SET THOUGH A HOUR PRESENTATION AND NOT .GET WHAT I AM PAYING FOR IN THE FIRST PLACE
Sounds like the same one I subscribe to…money map….all they seem to do is try and sell systems with lots of hype.I’m the same as you disillusioned.
You’re right. It’s the same group. Now I just happen to be getting tons of spam emails ironically. It’s Bellicum. I bought 15 calls at an average of .38 and I’m up 3 times my money so it’s time to get out within a few days. Buy the rumor sell the news.
I agree, I did the same thing. I would love to invest in this company but have no intention of paying someone else for the information.
The fn bstrdstake ur money and don’t give the name or ticker I fn hate these products so much they blow a big came then don’t perform they just want ur moola
I think it’s ZIOPHARM (ZIOP) Even they are not from a tiny town in Texas. They do have connections. Do the research.
I listened to the video as well Richard and I am interested in investing in this (just lost family member to cancer) but not sure how to even set up an account in order to purchase this once we figure out the small Texas lab’s name. Any help would be appreciated. This is going to be a wonderful thing, I believe.
BLCM…seems pretty conclusive. Are you able to read the other’s posts?
No it is not Ziop. Ziop is in Boston. Their Revenue is totally different from the amount stated in the “Teaser Article”, and they are scheduled to present in New York, not Madrid, Spain. BLCM is the likely candidate, because its characteristics and statistics match the article in question.
http://www.bellicum.com/product-candidates/cd19-program/
Maybe helpful? Maybe someone can help confirm relevance?
All accepted abstracts of the 22nd Congress are now published on the EHA Learning Center. Browse the abstracts by topic, allocation, abstract title or author.
(S146) BPX-501 DONOR T CELL INFUSION (WITH INDUCIBLE CASPASE 9 SUICIDE GENE) FACILITATES HLA-HAPLOIDENTICAL STEM CELL TRANSPLANT IN CHILDREN WITH BOTH HEMATOLOGICAL MALIGNANCIES AND NON-MALIGNANT CONDITIONS
Friday 15:45 – 15:57 [June 23, 2017]
Authors from:
Fred Hutchinson Cancer Research Center,Seattle,United States…
Dana Farber Cancer Institute,Boston,United States…
Bellicum Pharmaceuticals Inc.,Houston,United States…
among others.
https://www.ehaweb.org/congress-and-events/22nd-congress/program-by-day-2/
BLCM is “likely” the company in question. Supporting Facts:
1) BLCM announced that they will conduct at least two presentations at the European Hematology Association Presentation Europe June 23.
2. The revenue reported (388k) matches the teaser article.
3) BLCM is domiciled in Houston Texas.
Houston is NOT a small town, even though it is in Texas.
Also if the presentation is not about DC19, it doesn’t sound right.
The revenue reported sounds like a match though.
I don’t think it said small town. It said small lab in south Texas.
I think San Antonio it’s a small lab not a small town
as info, Bellicum also filed a patent appliction 12/13/16 that was just published last Thursday, 6/15/17, that could have been the trigger for the $2000 Biotech Insider newsletter solicitation.
here is the recent patent application information with Bellicum’s patent history: http://stks.freshpatents.com/Bellicum-Pharmaceuticals-Inc-nm1.php
and Bellicum’s 2016 annual report, which does reference the CD19:
http://ir.bellicum.com/phoenix.zhtml?c=253830&p=irol-reportsAnnual
and a May 15th press release with some interesting info about management and going to market: http://ir.bellicum.com/phoenix.zhtml?c=253830&p=irol-newsArticle&ID=2273082
Biggest investor is BAKER BROS ADVISORS L P. according to Reuters insider trading …. they have over 5MM shares, and just bought 166,000 shares less than 2 months ago.
According to Motley Fool, the Baker Bros have a track record of success in this arena in an article from 2015 (not related to Baker Bros, but … read for what they did 2 years ago – may shed light on their current play on Bellicum: https://www.fool.com/investing/general/2015/09/05/heres-why-the-baker-bros-are-gobbling-up-this-emer.aspx
well, I’ve just wasted 1/4 of my day….poke holes, or confirm if you can…I’m just a hack someday wanna be investor….appreciate any help on this!!!
HAPPY FATHER’S DAY
la storm…you did a great job…read through a lot of what you presented…concerned about the head medical scientist leaving as well as the company just operating on grant income supposedly solvent thru only Q1 2018 right now. The part about the Baker Bros. is uplifting, however is could be more speculative for them…they are only in for like 55M…they have 1.4 B in Seattle Genetics. Thanks for you hard work. I’m thinking I’ll put a little on BLCM – I don’t see them losing too fast anyway starting at 11.33…I just won’t put in more than I can afford to lose. Good Luck.
I TOTALLY AGREE WITH RICHARD!!! WHAT DID WE PAY FOR?? JUST A WAY TO SPEND MORE MONEY TO GET WHAT WE THOUGHT WE WERE PAYING FOR THE FIRST TIME. EVERY PRESENTATION ENDS WITH A SUBSCRIBE NOW TO GET THE INFORMATION YOU EXPECTED TO GET WITH THE FIRST SUBSCRIPTION. VERY DISAPPOINTED !!!!
Sadly, I have to agree. Join, get some information then pay up again for the next. No wonder they are rolling in the money pit.
Hi Hugh and Richard,
I looked at buying the subscription as well, glad i didn’t.
Ask for you money back… if the the information you have received
doesn’t give you the information you expected from there video sell.
And has left you guessing who the company is.
When you use a video, just move your cursor up to the upper right like you are going to exit. If there is a transcript to read instead in a drop-down that appears, click on it. You can now read the video script. Scroll to the bottom and see I they are pitching you to join something. Bet you’ll never see a symbol given in the actual video.
Bellicum Announces Clinical Presentations at the 22nd Congress of the European Hematology Association; http://ir.bellicum.com/phoenix.zhtml?c=253830&ut=1497852814&p=RssLanding&cat=news&id=2273891. Bellicum will be presenting June 23 at the European Hematology Association in Madrid, Spain.
Bellicum Announces Clinical Presentations at the 22nd Congress of the European Hematology Association; http://ir.bellicum.com/phoenix.zhtml?c=253830&ut=1497852814&p=RssLanding&cat=news&id=2273891. Bellicum will be presenting June 23 at the European Hematology Association in Madrid, Spain.
From all the research I have done and glad I did not pay for that money maker video. Bellicum Pharmaceutical is the company. Unless what he said from the video is to throw us off. These videos that charge all that money are rip-offs. You can cancel and get your money back, which you should do.
They most always warn you, that you cannot get your money back, before you sign on an expensive letter. Thank you all who have researched this and found Bellicum Pharma (BLCM). I think I’ll buy some stock, or should I buy some call options?
Leena, becareful. I bought some call options last Friday on Bellicum and I sold them this Friday morning and made a great profit. I bought the rumor and sold the news. I think they were hyping the stock by giving you just enough information without telling you the company so they wouldn’t get in trouble by mentioning the name and trying to make you pay a ton of money for their newsletters and recommendations for whatever their pump and dump scheme was. If you buy the stock you have to spend for example 1300 for 100 shares. It’s speculative and you could lose some of your money or be forced to sell at a loss or hold for a while. My opinion is to wait for it to pull back and if you want to gamble now that the hype is over then by a few close to the money call options a few months out for a few hundred dollars and see what happens. If the stock runs up again than your few hundred dollars might turn into a a thousand dollars. That’s with just a couple of point moves vs what you would make if you bought the stock and it went up a few dollars. Do research and good luck.
And it’s not BPTH.
It’s a small company, so they will need a large Pharma like Kite and Novartis to for production and distribution, but they own the third vital paten
I found it.It is (BPTH). Stocks at .35 cents
In Texas a small town Bellaire.
I am going to accept the bpth stock
No my friend, it is BLCM. Your pick does not match in annual revenues.
BLCM’s revenue exactly matches the value mentioned in the article. The article did not mention a small town, instead it mentioned small company and small lab.
look! a small town … Bellaire…
May be it is BPTH…
trying to pump this one. lol
BPTH market cap is 35 Million not 388 million.
That same video people had promoted PMTS last year and then PMTS was chrged with insider trading issues and the stock went down. Only the Money Map people made Miliions of Money
My uncle recently passed from cancer and was offered CD-19 after all else failed. The Doctor’s also indicated that it only works 20% of the time and has side-affects (not mentioned) the Doctor’s also indicated that it take 2/3 months to work if he does.
My uncle recently passed due to cancer. He was then offered CD-19 when all else failed however, his Doctors did not recommend the procedure as they indicated it only worked 20% of the time and had side-affects (not mentioned).